Global Regenerative Medicine market size will reach 290 million US$ by 2025, from 190 million US$ in 2018, at a CAGR of 5.9% during the forecast period. In this study, 2018 has been considered as the base year and 2019-2025 as the forecast period to estimate the market size for Regenerative Medicine.
Avalanche airbags are safety gear designed to prevent the wearer from being buried while skiing and mountaineering. In an avalanche, larger objects rise to the surface, while smaller objects sink to the bottom. An airbag system incorporated into a backpack, with a large balloon or balloons that inflates at the pull of a cord, is designed to make the person wearing it larger so that they naturally rise to the surface of the snow.
With the rising popularity of ski touring and freeriding many manufacturers notice that there is a need for more protection while being in the freedom of backcountry or high alpine. So nowadays, avalanche airbag backpack became a usual piece of equipment next to your regular avalanche safety equipment: avalanche beacon, probe, and shovel. And thanks to a high demand for this piece of equipment, avalanche airbag backpacks are no longer considered a luxury good but are getting more and more affordable each season. But avalanche airbag packs are only helpful in critical situations of avalanche slides, they in no way guarantee survival and they are not meant to be used as the only mean of protection, and uncertainties related to survival percentages is limiting growth for the Avalanche Airbags market.
Direct-to-consumer is the most lucrative sales channel for avalanche airbags. Consumer familiarity, and availability of a wide range remain the key USPs of this sales channel. Specialty stores follow suit. These two sales channels collectively account for nearly two-third of all avalanche airbags sold globally.
This industry study presents the global Regenerative Medicine market size, historical breakdown data (2014-2019) and forecast (2019-2025). The Regenerative Medicine production, revenue and market share by manufacturers, key regions and type;
The consumption of Regenerative Medicine in volume terms are also provided for major countries (or regions), and for each application and product at the global level. Market share, growth rate, and competitive factors are also evaluated for market leaders ABS Protection GmbH, Mammut, etc.
The following manufacturers are covered in this report:
ABS Protection GmbH
Mammut
Clarus Corporation
Backcountry Access
Scott
Ortovox
ARVA
Osprey Packs
The North Face
Dakine
Mystery Ranch
Millet(Calida Group)
Motorfist
Deuter
Regenerative Medicine Breakdown Data by Type
Mono Avalanche Airbags
Dual Avalanche Airbags
Regenerative Medicine Breakdown Data by Application
Skiing
Climbing
Hiking
Others
Regenerative Medicine Production by Region
United States
Europe
China
Japan
South Korea
India
Other Regions
Regenerative Medicine Consumption by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives are:
To analyze and research the global Regenerative Medicine status and future forecastinvolving, production, revenue, consumption, historical and forecast.
To present the key Regenerative Medicine manufacturers, production, revenue, market share, SWOT analysis and development plans in next few years.
To segment the breakdown data by regions, type, manufacturers and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Regenerative Medicine :
History Year: 2014 - 2018
Base Year: 2018
Estimated Year: 2019
Forecast Year: 2019 - 2025
This report includes the estimation of market size for value (million USD) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Regenerative Medicine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Regenerative Medicine Market, By Product Type
7.1. Regenerative Medicine Market, By Product Type, 2021-2028
7.1.1. Therapeutics
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Tools
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Banks
7.1.3.1. Market Revenue and Forecast (2016-2028)
7.1.4. Services
7.1.4.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Regenerative Medicine Market, By Therapeutic Category
8.1. Regenerative Medicine Market, By Therapeutic Category, 2021-2028
8.1.1. Dermatology
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. Musculoskeletal
8.1.2.1. Market Revenue and Forecast (2016-2028)
8.1.3. Immunology & Inflammation
8.1.3.1. Market Revenue and Forecast (2016-2028)
8.1.4. Oncology
8.1.4.1. Market Revenue and Forecast (2016-2028)
8.1.5. Cardiovascular
8.1.5.1. Market Revenue and Forecast (2016-2028)
8.1.6. Ophthalmology
8.1.6.1. Market Revenue and Forecast (2016-2028)
8.1.7. Others
8.1.7.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global Regenerative Medicine Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.1.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.1.3.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.1.4.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.2. Europe
9.2.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.2.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.2.3.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.2.4.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.2.5.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.2.6.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.3. APAC
9.3.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.3.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.3.3.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.3.4.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.3.5.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.3.6.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.4. MEA
9.4.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.4.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.4.3.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.4.4.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.4.5.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.4.6.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.5. Latin America
9.5.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.5.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.5.3.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, By Product Type (2016-2028)
9.5.4.2. Market Revenue and Forecast, By Therapeutic Category (2016-2028)
Chapter 10. Company Profiles
10.1. Integra LifeSciences Corporation
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. MiMedx Group, Inc.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. AstraZeneca
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. F. Hoffmann-La Roche Ltd
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Merck & Co., Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Pfizer Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Baxter.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers